PAM
IART icon

Paradigm Asset Management’s Integra LifeSciences IART Stock Holding History

Paradigm Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,100
Closed -$551K – 454
2017
Q2 		$551K Sell
10,100
-10,400
-51% -$497K 0.11% 210
2017
Q1 		$864K Buy
+20,500
New +$876K 0.16% 138

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Paradigm Asset Management's IART Position: Q3 2017 in Review

Paradigm Asset Management sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 10,100 shares — an estimated $551K sold.

Paradigm Asset Management first reported a position in IART in Q1 2017 and held it in 2 quarters. The position peaked at $864K in Q1 2017. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • Paradigm Asset Management reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • Paradigm Asset Management sold 10,100 Integra LifeSciences shares in Q3 2017, an estimated $551K.
  • Paradigm Asset Management first reported a position in Integra LifeSciences in Q1 2017 and held it in 2 quarters.
  • Paradigm Asset Management's Integra LifeSciences position peaked at $864K in Q1 2017.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Paradigm Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.